Generation of Germline-Competent Rat Induced Pluripotent Stem Cells by Hamanaka, Sanae et al.

















1Japan Science Technology Agency, Exploratory Research for Advanced Technology (ERATO), Nakauchi Stem Cell and Organ Regeneration Project, Tokyo, Japan,
2Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan, 3Center for
Genetic Analysis of Behavior, National Institute for Physiological Sciences, Okazaki, Japan, 4School of Life Science, The Graduate University for Advanced Studies, Okazaki,
Japan
Abstract
Background: Recent progress in rat pluripotent stem cell technology has been remarkable. Particularly salient is the
demonstration that embryonic stem cells (ESCs) in the rat (rESCs) can contribute to germline transmission, permitting
generation of gene-modified rats as is now done using mouse ESCs (mESCs) or mouse induced pluripotent stem cells (iPSCs;
miPSCs). However, determinations of whether rat iPSCs (riPSCs) can contribute to germ cells are not published. Here we
report the germline competency of riPSCs.
Methodology/Principal Findings: We generated riPSCs by transducing three mouse reprogramming factors (Oct3/4, Klf4,
and Sox2) into rat somatic cells, followed by culture in the presence of exogenous rat leukemia inhibitory factor (rLIF) and
small molecules that specifically inhibit GSK3, MEK, and FGF receptor tyrosine kinases. We found that, like rESCs, our riPSCs
can contribute to germline transmission. Furthermore we found, by immunostaining of testis from mouse-rat interspecific
chimeras with antibody against mouse vasa homolog, that riPSCs can contribute to embryonic development with chimera
formation in mice (rat-mouse interspecific chimeras) and to interspecific germlines.
Conclusions/Significance: Our data clearly demonstrate that using only three reprogramming factors (Oct3/4, Klf4, and
Sox2) rat somatic cells can be reprogrammed into a ground state. Our generated riPSCs exhibited germline transmission in
either rat-rat intraspecific or mouse-rat interspecific chimeras.
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Introduction
Mouse embryonic stem cells (ESCs), first established in 1981,
were originally generated from the inner cell mass of mouse
blastocysts. Because they are pluripotent, have potentially unlimited
capacity for self-renewal, and can contribute to transmitted
germlines (exhibit germline competency), mouse ESCs (mESCs)
have constituted powerful tools when generating genetically
modified mice to understand gene functions and to create mouse
models for human diseases [1]. In 2006, Yamanaka et al. reported
the generation of pluripotent stem cells from mouse somatic cells by
the enforced expression of four transcription factors (Oct3/4, Sox2,
c-Myc, and Klf4) selected from genes known to be expressed in
ESCs. They referred to these cells as induced pluripotent stem cells
(iPSCs). Like mESCs, which they resemble, mouse iPSCs (miPSCs)
express alkaline phosphatase (ALP), can generate chimeric mice,
and can take part in germline transmission [2] [3]. The discovery of
iPSCs, a great step forward in stem-cell research, holds out the
promise of development of novel therapeutic strategies by
generating iPSCs from patients. Since 2006, besides mESCs and
miPSCs, pluripotent stem cells from several mammalian species
have been established, including rat [4] [5] [6] [7], rabbit [8] [9],
pig [10] [11], monkey [12] [13] [14], and human [15] [16] [17].
Although such iPSCs express a panel of pluripotency markers like
SSEA-1, 3, 4, ALP, and Oct3/4, only mESCs and miPSCs can
generate chimeras. However, remarkable progress has been made
recently, and rat pluripotent stem cell technology now is capable of
generatingchimericrats.In2008,Ying et al.reported establishment
of rat ESCs (rESCs) with use of two or three kinds of kinase
inhibitors, including glycogen synthase kinase 3 (GSK3) inhibitor,
mitogen-activated protein kinase kinase (MEK) inhibitor, and
fibroblast growth factor (FGF) receptor tyrosine kinase inhibitor in
the culture medium. These inhibitors have been thought to
maintain a ground state of pluripotency in mESCs [18] and can
support efficient derivation and maintenance of rESCs, permitting
generation of chimeric rats, with germline transmission [19] [20].
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successfully established. As riPSCs can differentiate into all three
germ layers in vitro and in vivo [21] [22], and can contribute to
generating chimeric rat [16]. However, germline competency of
riPSCs has not been reported to date.
The rat has been used as a model for studies of physiology,
pharmacology, toxicology, nutrition, behavior, immunology, and
neoplasia. Its size, its ease of manipulation, and the availability of
many kinds of spontaneous models for diseases such as
hypertension and diabetes have made the rat the preferred choice
for most of these fields, while the mouse has become the leading
mammal for experimental genetics. To extend experimental
genetics into the rat could be of great value: Generation of iPSCs
from disease-model rats could help clarify the pathogenesis of
various disorders, particularly if germline-competent iPSCs are
necessary to demonstrate curative effects, as when the mutated
gene that is responsible for disease can be corrected in riPSCs by
homologous recombination and the curative effect can be
observed in F1 rats derived from gene-corrected riPSCs.
Here we report for the first time that adding two or three kinds of
kinase inhibitor and rLIF to culture medium can generate germline-
competent riPSCs. Moreover, we generated reprogrammable rats
from riPSCs that were created by infection of three reprogramming
factors (Oct3/4, Klf4,a n dSox2) via an inducible lentiviral vector.
Results
Generation of riPSCs from rat embryonic fibroblasts
To generate germline-competent riPSCs, we initially infected
Wistar (WI) or Dark Agouti (DA) rat embryonic fibroblasts (REFs)
from embryonic day 14.5 or 15.5 (E14.5 or E15.5) with a lentiviral
vector carrying three mouse reprogramming factors (Oct3/4, Klf4,
and Sox2) controlled by a tetracycline-responsive regulatory
element and with Ubc-promoter - driven reverse tet transactivator
(rtTA) and EGFP (Fig. 1A). We added doxycycline (Dox) to the
culture medium on the day of infection (day 0), with rat LIF (rLIF)
added to medium on day 1.
Infected REFs were seeded onto mitomycin-C treated mouse
embryonic fibroblasts (MEFs) and the medium was changed to
serum-free medium (N2B27/F12) containing Dox and rLIF on
day 3. On day 7 MEK inhibitor (PD0325901) and GSK3 inhibitor
(CHIR99025; 2i) or 2i and FGF receptor inhibitor (SU5409; 3i)
were added to the medium (Fig. 1B).
Morphologically ES-like colonies appeared from day 10. They
expressed EGFP and were of typical dome shape (Fig. 1C).
Independent colonies were selected and each colony was
expanded in N2B27/F12 medium containing rLIF, 2i, or 3i and
with or without Dox. These riPSCs could be sustained for over 25
passages. All ES-like colonies stained for ALP, indicating that
generated riPSCs were pluripotent (Fig. 1D). Finally we isolated
several riPS clones from both WI and DA fibroblast and chose six
clones from WI (T1-3 (referred as riPS#3 in our previous report
[23]), T1-4, T1-15, T3-2, T3-3 and T3-11) and two clones from
DA (T4-27 and T4-30) for further analysis.
Pluripotency of iPS cells
To evaluate the pluripotency of riPSCs further, we immuno-
stained riPSCs with antibodies against Nanog and Oct3/4 (markers
of pluripotency) [16] [24] [25]. RiPSCs expressed both Nanog and
Oct3/4 (Fig. 2A). We also examined by RT-PCR the expression of
pluripotency marker genes, including Oct3/4, Klf4, Fgf4, Eras,
Rex1, and Tdgf2. To detect transgene expression, we designed the
primers to amplify sequence between T2A and Sox2. As shown in
Fig. 2B, transgene expression was detected only under with Dox
addition, indicating that expression via the lentiviral vector was
tightly controlled by a tetracycline-responsive element. We also
found that pluripotent marker genes were expressed at levels
comparable to those in rESCs; the presence of Dox made no
difference (Fig. 2B). The distal enhancer of Oct3/4 expression
reportedly is un-methylated in ESCs (a feature of pluripotency)
[26]. To analyze DNA methylation status in riPSCs, we conducted
bisulfite-sequencing analysis of genomic regions within the distal
enhancer of Oct3/4 in riPSCs and rESCs. In rESCs and riPSCs
the distal enhancer of Oct3/4 was largely unmethylated, consistent
with results from immunostaining and RT-PCR (Fig. 2C). By
contrast, in REFs, where Oct3/4 expression was silenced, the Oct3/
4 enhancer was highly methylated (Fig. 2C).
Next we examined the capacity of riPSCs for in vivo
differentiation. We injected 0.5–1610
6 riPSCs into testis of non-
obese diabetic/severe combined immune deficient mice and
assessed teratoma formation, with microscopy of hematoxylin/
eosin (HE) - stained sections, 4 to 10 weeks after injection. Tumors
reached 15 mm or more in diameter and included elements
derived from three germ layers (muscle, cartilage, neural tissues,
epidermis, gut-like tissues). These results indicate that our riPSCs
had been reprogrammed into a pluripotent state and, like ESCs,
possessed the capacity for differentiation into three germ layers
(Fig. 2D).
Generation of chimeric rats
Before attempting to generate chimeric rats, we evaluated riPSC
karyotypes; they were normal (42XY; Fig. 3A). However, trisomy
of chromosome 9 was encountered in clones T1-3, T1-4 and T1-
15 (rate: 2/50, 6/50 and 3/50 respectively) cultured with 3i
(Figure S1), as observed [20]. As no chromosome abnormality was
found in clones T3-2, T3-3 and T3-11 derived from cells cultured
with 2i, we continued to culture riPSCs with 2i thereafter. Next we
examined the effect of Dox in culture medium on generation of
chimeras. WI riPSCs cultured with Dox or without Dox were
injected into (WI6WI) rat blastocysts. EGFP expression was
assessed by fluorescence microscopy of E15.5 embryos. Using
riPSCs cultured with Dox until blastocyst injection, chimeric rat
embryos were generated at a ratio of 66%; without Dox, the rate
was 100%. Because half life of Dox is 24 hrs, transgene expression
continues in embryo after blastocyst injection. This continuous
expression of transgene in embryo might influence the chimera
contribution. Therefore, for efficient generation of chimeric rat,
we cultured riPSCs without Dox thereafter (Fig. 3B, Table 1).
Next we injected riPSCs from clone T1-3 into (DA6WI) F1
blastocysts to permit identification of chimeras by coat color.
Using foster mothers and 43 blastocysts into which riPSCs were
injected, we obtained four pups of which two were chimeras
(Table 1).
Because rat (DA6WI) F1 blastocysts might have potentially low
reproduction ability, we then tried to generate chimeras by using
rat (WI6WI) blastocysts, detecting chimerism by evaluating
expression of EGFP. We obtained 11 chimeras in 18 liveborn
pups using clone T1-3 and 7 chimeras in 13 liveborn pups using
clone T3-11. We also injected T4-27 and T4-30 into rat (WI6WI)
blastcysts and obtained 2 chimeras in 6 liveborn pups and 15
chimeras in 26 liveborn pups respectively (Fig. 3C, Table 1).
These results indicate that riPSCs generated in medium
containing 2i can contribute to generating chimeric rats.
Germline transmission of riPSCs
To address whether these riPSCs could contribute to germline
transmission, generated male chimeric rats were mated with wild-
type female WI rats.
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expressed EGFP from three chimeric rats derived from riPSC
clones T1-3 or T3-11 (Fig. 4A, Table 1, Table S1). FACS
analysis revealed that REFs established from F1 rats also
expressed EGFP (Fig. 4B) and, as shown in Fig. 4C, proviral
DNA was detected by genomic PCR. For further confirmation of
the germline transmission of riPSCs, we attempted to regenerate
riPSCs from fibroblasts of F1 rats. Because the clone T1-3
riPSCs from which F1 rats were generated were established using
a Dox-inducible lentiviral vector, exposure to Dox should allow
riPSCs to regenerate from F1 rat somatic cells. REFs from F1
rats seeded on MEFs and cultured in medium containing Dox.
ESC-like colonies began to appear from day 10 and by day 16
and 2,000 REFs had given rise to 16.6 ES-like colonies (triplicate
assay; Fig.4E). The frequency of regeneration, calculated as the
number of colonies/20006100 was 1% on day 16 and 4.7% on
day 20.
Chimeras derived from riPSC clones T4-27 and DA T4-30 had
no offspring that expressed EGFP or had black eyes (Because eye
color of DA is black and of WI is red, we can identify F1 rat by
black eye color).
However, we found that the seminiferous tubules of these DA
chimeras expressed EGFP (Figure S2A). Moreover, immunostain-
ing revealed that germ cells in testis from chimeric rats which were
derived from riPSC clone T4-30, contained mouse vasa homolog
(MVH) and EGFP double positive cells, indicating that clone T4-
30 riPSCs can contribute to germ line transmission (Figure S2B).
On the other hand, we could not detect MVH and EGFP double
Figure 1. Generation of rat iPS cells from rat embryonic fibroblasts. (A) Schema of inducible lentivirus vector. XbaI enzyme restriction site
exists between Ubiquitin-C (Ubc) promoter and reverse tet transactivator (rtTA) element. (B) Schematic time schedule of riPSCs generation. (C)–(D)
Morphology of generated riPSCs (passage P0); bright field and fluorescent field (C). ALP staining after clonal passage (D).
doi:10.1371/journal.pone.0022008.g001
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riPSCs (data not shown).
To confirm provirus copy number, genomic DNA from riPSCs
and from F1 REFs were analyzed by Southern blot (Fig. 4D). Four
riPSC lines (lanes 1–4) showed different integration patterns
containing one to three transgenes. Progeny derived from clone
T1-3 riPSCs (lanes 5–7) carried provirus copies inherited from
their riPSCs of origin. Either two or three provirus copies were
integrated into the genomes of F1 rats (Table S1).
Tumorigenesis has been observed in chimeric mice (and their
offspring) derived from iPSCs generated by transduction of four
reprogramming factors (c-Myc, Oct4, Sox2, and Klf4), and has been
ascribed to reactivation of c-Myc [3]. In our study, however, no
tumors developed in chimeric rats or their progeny during
observation for over six months.
As a whole, these data show that riPSCs generated by our
method can contribute to germline transmission and pose a risk of
tumorigenesis lower than that observed using miPSCs generated
by a different method.
Generation of interspecific chimeras between mouse and
rat with contribution to germline chimerism
We have recently reported successful generation of rat-mouse
interspecific chimeras by injection of riPSCs into mouse blastocyst
[23]. To assess if the riPSC clones T1-3 or T3-11 can contributed
to embryonic development with chimeric formation in wild type
Figure 2. Characterization of rat iPS cells. (A) Immunofluorescence staining for Oct3/4 and Nanog in rat iPS cells (riPSCs). (B) RT-PCR analysis of
transgene T2A-Sox2 and endogenous ES marker genes with or without doxycycline culture. RiPSC clones (riPSCs WI T3-11 and T1-3) express ESC
markers. Rat and mouse embryonic fibroblast cells (REFs or MEFs) were used as negative controls. b-actin was used as a loading control. (C) Bisulfite
genomic sequencing of the distal enhancer region of Oct3/4. Open and closed circles indicate unmethylated and methylated CpGs, respectively. (D)
Hematoxylin/eosin staining of teratoma derived from rat iPS cells. Teratoma is composed of various types of tissues: Gut-like epithelium (endoderm),
muscle and cartilage (mesoderm), epidermis, and neural tissue (ectoderm).
doi:10.1371/journal.pone.0022008.g002
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the expression of EGFP in embryonic fibroblasts (Fig. 5A).
Embryos derived from both riPSC clones expressed EGFP,
indicating that most riPSC clones can form chimeras (Fig. 5B).
Moreover, immunostaining found MVH and EGFP double
positive cells in testis from interspecific chimeras (n=2) derived
from riPSCs T1-3 (Fig. 5C). These data provide conclusive
evidence that these riPSCs are pluripotent and that they can
contribute to both interspecific chimera formation and germline
transmission.
Discussion
We here show that infection with a lentiviral vector carrying
three mouse reprogramming factors (Oct4, Klf4, and Sox2) and
culture in the presence of two kinds of kinase inhibitors (MEK
inhibitor and GSK3 inhibitor) permit efficient establishment and
maintenance of riPSCs from REFs. Established riPSCs possess all
the key features of rESCs, such as expression of pluripotency
markers Oct4, Nanog, and E-ras, long-term self-renewal, the
capacity to differentiate into derivatives of all three germ layers,
and, most importantly, the ability to produce chimerism with high
efficiency and to contribute to transmission through the germline.
MiPSCs generated by introducing four reprogramming factors
(Oct3/4, Sox2, Klf4, and c-Myc) are able to produce germline-
competent chimeras.
However, a drawback in this four-factor system is reactivation of
the c-Myc retrovirus, which increases tumorigenicity in chimeric
mice and their progeny. On the other hand, no tumors were
observed in mice derived from iPSCs generated by introducing
three factors (Oct3/4, Sox2, and Klf4) [27]. Therefore, we used
three factors (Oct3/4, Klf4, and Sox2), eliminating c-Myc, with a
special emphasis on escape from tumor development. As expected,
we observed no tumorigenesis in chimeric rats or their progeny,
with monitoring for over six months.
Two main factors can be conceived to affect the successful
generation of germline chimeras. One is the conditions under
which riPSCs are generated and cultured. In recent studies by
Ping Li et al., rESCs were generated using serum-free N2B27
medium containing mLIF and a combination of two or three
kinase inhibitors (2i/3i) [19] [20]. RiPSCs also have been
generated using knockout DMEM medium containing knockout
serum replacement (KSR), 2i, A83-01 and mLIF [16]. Because
successful germline transmission was reported only in the rESCs
study, we generated riPSCs using N2B27 medium and the 2i/3i
culture method. The other is the interaction between iPSC strain
and host blastocyst strain. In this study, high efficiency of germline
transmission was achieved by injection of WI riPSCs into WI
blastocysts (donor cell : host blastocyst combination WI : WI) and
of DA riPSCs into WI blastocysts (DA : WI). Other studies have
generated rESC germline chimeras in the combinations DA : F344
[16,19], WI :WI and DA/WI [28], and WI-LEA : WI, WI : WI,
WI : LEA, and LEA : WI [29]. So far, only a few combinations of
iPSCs strains and blastocyst strains have successfully generated
germline chimeras. Although we could not obtain offspring from
DA riPSCs, we may need to test different strains of blastocysts for
more efficient germline transmission.
As in our previous report of interspecific chimeras [23], the
riPSCs generated in this study were able to contribute interspe-
cifically to chimera generation and interspecifically to germ cell
lineages, indicating that these riPSCs were highly reprogrammed.
Taken together, our results demonstrate that rat somatic cells
can be reprogrammed to ground state with germ line competence
by transduction of only three reprogramming factors (Oct3/4, Klf4,
Figure 3. Generation of chimeric rat derived from rat iPS cells.
(A) Cytogenetic analysis, riPSCs; G-band staining. Representative data
(WI riPSC clone T3-11, passage 7) indicate a chromosomal number of 42,
including an XY gender chromosome. (B) Efficiency of chimera rat
generation in culture, with or without doxycycline. (C)–(D) Generation
of chimeric rat. (C) Analysis of E15.5 material derived from WI riPSCs
injected into WI blastocysts. EGFP indicates riPSC-derived cells. (D)
Chimeric rats derived from DA riPSCs injected into WI blastocysts.
Brown coat color indicates derivation from DA riPSCs. One-week-old
pups; left pup (white) not chimeric (left panel). Three-month-old
chimeric rat; eye color also is brown (right panel).
doi:10.1371/journal.pone.0022008.g003
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studies using the rat as a useful animal model.
Materials and Methods
Cell culture
Rat embryonic fibroblasts (REFs) were derived from embryonic
day (E)14.5 or E15.5 Wistar (WI) and Dark agouti (DA) rat
embryos. WI and DA rats were purchased from Japan SLC
(Shizuoka, Japan). REFs were cultured in Dulbecco’s modified
Eagle’s medium (DMEM; Sigma, St. Louis, MO) supplemented
with 10% fetal bovine serum (FBS; Hana-Nesco Bio, Moregate
BioTech, Australia), 1% L-glutamine penicillin streptomycin
(Sigma, St. Louis, MO). Rat iPS cells (riPSCs) were maintained
on mitomycin-c treated mouse embryonic fibroblasts (MEFs) in
N2B27 medium (Invitrogen, Carlsbad, CA) [30] supplemented
with 1,000 U/ml of rat leukemia inhibitory factor (LIF, ESGRO
Millipore, Bedford, MA), 3 mM of GSK3 inhibitor CHIR99021
(Axon Medchem BV, Groeningen, The Netherlands), and 1 mM
of MEK inhibitor PD0325901 (Stemgent, Cambridge, MA), with
or without FGF receptor inhibitor SU5402 (2 mM; Calbiochem,
La Jolla, CA). RiPSCs were trypsinized (0.05% trypsin-EDTA:
Sigma, St. Louis, MO) into single cells and plated into new wells
with a MEFs feeder every 3 or 4 days. Rat embryonic stem cells
(rESCs) were maintained as described protocol [28].
Lentiviral vector; generation of riPSCs
The cDNAs of mouse Oct3/4, Sox2, and Klf4 were inserted into
a doxycycline-inducible system lentiviral vector that also included
EGFP inserted downstream from a Ubiquitin-C promoter.
To establish riPSCs, Wistar and DA REFs were transduced with
this lentiviral vector. Two days later, transduced cells were
trypsinized and split among MEFs feeder wells. Eight days later
(day 10 after transduction), generated colonies were picked up and
mechanically dissociated. Dissociated cells (riPSCs) were plated
into new wells with a MEFs feeder (96-well plates). The riPSCs
uniformly expressed EGFP under the control of the Ubiquitin-C
promoter.
Blastocyst injection and generation of chimeric rats
Chimeric rats were generated by a conventional method:
RiPSCs were microinjected into day 4.5 blastocysts of WI6DA-F1
or WI female rats, followed by transfer into host uteri as described.
The resultant chimeric rats were mated with WI rats to obtain
their progeny [23] [28].
For generation of interspecific chimeras between mouse and rat,
we employed conventional method of chimeric mice generation
[31]. RiPSCs were microinjected into day 3.5 blastocysts of
C57BL/6 or ICR female mice (purchased from SLC Japan),
followed by transfer into host uteri as described [23].
ALP staining and immunostaining
Histochemical ALP assays were conducted with Vector Red
Alkaline Phosphatase Substrate Kit I (Vector Laboratories,
Burlingame, CA) according to the manufacturer’s instructions.
For immunofluorescence assays, cells were fixed in 4%
paraformaldehyde for 10 min and washed twice with PBS. The
fixed cells were incubated in MAXblocking medium (Active Motif,
Carlsbad, CA) for 30 min at room temperature (RT) for blocking.
The cells were then incubated with primary antibody for one hour
at RT in blocking buffer. Cells were then washed with PBS and
incubated with secondary antibody in PBS for 30 min at RT.
Thereafter the cells were washed with PBS and 49,6 -diamidino-2-
phenylindole (DAPI) was added for nuclear staining.
Primary antibodies used were rabbit anti-mouse Oct3/4 antibody
(Bioworld Technology, Minneapolis, MN, 1:100) and rabbit anti-
mouse Nanog antibody (ReproCELL, Kanagawa, Japan, 1:100).
Secondary antibodies were Alexa Fluor 546 conjugated goat anti-
rabbit IgG antibody (1:300) or Alexa Fluor 546 conjugated goat anti-
mouse IgG antibody (1:300) (Invitrogen, Carlsbad, CA, 1:300).
Testes were fixed in 4% paraformaldehyde and PBS+sucrose
solutions ranging from 10% to 30% (w/v) sucrose before freezing
in optimal cutting temperature medium (Tissue Tek, Sakura
Finetek, Torrance, CA) and cryostat sectioning. Fixed sections
were incubated in MAXblocking medium for 30 min at RT for
blocking. Each section was incubated with primary antibody for
1 hr at RT and with secondary antibody for 1 hr at RT. Primary
antibodies used were goat anti-GFP (Abcam, Cambridge, MA,
1:100) and rabbit anti-DDX4/MVH (as a primitive germ cell
marker; Abcam, 1:100). Secondary antibodies were Alexa Fluor
546 conjugated donkey anti-rabbit IgG antibody and Alexa Fluor
488 conjugated donkey anti-goat IgG antibody (Invitrogen, 1:300).
After antibody treatment, sections were mounted with Vectashield
(Vector Laboratories), a mounting medium containing DAPI for
nuclear counterstaining, and sections were observed under
fluorescence microscopy.
Genomic PCR and RT-PCR
Genomic DNA was extracted using QIAamp DNA Mini Kits
(Qiagen, Germantown, MD) or the phenol-chloroform method.
















Passage number P20 P14 P14 P14 P15 P7 P8
Dox added (2)( 2)( +)( 2)( 2)( 2)( 2)
Host blastcyst WI6DA WI6WI WI6WI WI6WI WI6WI WI6WI WI6WI
Number of Blastcysts injected 43 13 12 39 33 28 42
Developed to fetus N/A 5 (38%) 3 (25%) N/A N/A N/A N/A
Developed to pups 4 (9%) N/A N/A 18 (46%) 13 (40%) 6 (21%) 26 (62%)
Number of chimeras 2 (50%) 1M,1F 5 (100%) 2 (66%) 11 (61%) 4M, 7F 7 (54%)4M, 3F 2 (33%) 1M, 1F 15*
1 (58%) 7M, 7F
Number of germline chimeras N/A N/A N/A 2/3 M 1/4 M 0/1 M 2/5 M
N/A: not applicable.
*1: One chimera died before weaning.
doi:10.1371/journal.pone.0022008.t001
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(Takara Bio, Shiga, Japan). Total RNA prepared using the
RNAeasy kit (Qiagen) was used as a template for reverse
transcription-polymerase chain reaction III (RT-PCR). For
genomic PCR and RT-PCR of GFP and b-actin, EX Taq HS
(Takara) was used under the following conditions: 94uCf o r
1m i n ,f o l l o w e db y3 0o r3 5c y c l e so f9 4 uC for 30 sec, annealing
temperature (from 50uCt o6 2 uC) for 30 sec (for genomic PCR)
or 1 min (for RT PCR), and 72uC for 30 sec, with a final
extension at 72uC for 7 min. PCR products were visualized with
Figure 4. Germline transmission of riPSCs. (A) EGFP of offspring (E15.5; neonate) of chimeric rats. (B) FACS analysis of rat embryonic fibroblasts
(REFs) established from F1 rats. (C)GenomicPCR, F1rats. Some F1rats harboredEGFP. GenomicDNAwas obtained from F1 REFs or from tail. (D)Provirus
copy numbers determined by Southernblot analysis. Lane1: WI riPSCs, clone T1-3; 2: WI riPSCs, clone T3-11; 3: DA riPSCs, clone T4-27; 4: DA riPSCs, clone
T4-30; 5–7: EGFP-expressing F1 rats. (E) REFs established from F1 rats using Dox were reprogrammable: Re-generated riPSCs expressed EGFP and ALP.
doi:10.1371/journal.pone.0022008.g004
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are listed in Table S2 with annealing temperature and PCR
product size.
Southern blotting
High-molecular-weight DNA was obtained from riPSCs or
generated REFs. Genomic DNA was digested with XbaI,
electrophoresed (1% agarose gel), transferred to a nylon
membrane (Hybond-XL: Amersham Biosciences GE Healthcare,
UK), and hybridized to [a-
32P]dCTP (deoxycytidine 50-triphos-
phate)-labeled rtTA sequence which is encoded in doxycyclin
inducible lentivirus vector.
As the restriction enzyme XbaI cut the vector at one site, the
number of fragments hybridized with the probe is considered to be
the number of provirus copies integrated into the host genome.
Hybridization signals were detected with an auto image analyzer
(FLA 5100, Fuji Film, Tokyo, Japan) after exposure to an imaging
plate.
Bisulfite sequencing
Genomic DNA was extracted with a genomic DNA purification
kit (QIAGEN).
200 ng of genomic DNA from each sample was treated with a
Methylamp DNA modification sample kit (Epigentek, Brooklyn,
NY) to convert the unmethylated cytosine to uracil according to
the manufacturer’s instructions. The promoter region of Oct4 was
amplified by PCR using EX Taq HS (Takara), cloned into the
pCR 2.1 vector (Invitrogen), and sequenced with M13 reverse and
forward primers. PCR primers are listed in Table S2.
Karyotype analysis
Karyotype analysis was performed with standard methods
(Nihon Gene Research Laboratories, Miyagi, Japan).
Teratoma formation
A suspension of 0.5,1.0610
6 single cells was injected intra-
testis into each testis of 6- to 10-week-old non-obese diabetic/
Figure 5. Generation of interspecific chimeras between mouse and rat. (A) RiPSCs injected into mouse blastocysts; analysis, E13.5. EGFP of chimeric
mouse (E13.5) generated using rat iPSCs. (B) EGFP (%) of chimerism was shown by FACS analysis of chimeric mouse embryonic fibroblasts (MEFs/REFs)
established from F1 rats. (C) Immunostaining of chimeric rats. HMV/DTT (Alexa546) or EGFP fluorescence was observed in testis. EGFP was derived from riPSCs.
doi:10.1371/journal.pone.0022008.g005
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were harvested and processed for hematoxylin/eosin staining.
Cell surface analysis
To detect chimerism, REFs and fetal liver cells from riPSC-
derived chimeric rats and offspring (E14.5–15.5) were stained with
phycoerythrin (PE) - conjugated mouse anti-rat CD45 antibody
(OX-1, Biolegend), biotin-conjugated mouse anti-rat CD54
antibody (ICAM-1, 1A29, BD Biosciences PharMingen, San
Diego, CA) and Alexa Fluor 647-conjugated goat anti-mouse IgG
antibody (BD Biosciences PharMingen). Peripheral blood cells
were also stained with PE-conjugated mouse anti-rat CD45
antibody. All stained cells were analyzed by cytometry using
FACSCanto II (BD Bioscience).
All experiments were performed under institutional guidelines.
Animal experiments were performed with approval of the
Institutional Animal Care and Use Committee of the Institute of
Medical Science, University of Tokyo (permit numbers: A09-29,
A09-30, A10-23) and the Institutional Animal Care and Use
Committee of the National Institute for Physiological Sciences
(permit number: 11A022).
Supporting Information
Figure S1 Karyotype analysis of cells cultured with 3i.
Cytogenetic analysis, riPSCs; G-band staining. Representative
data of WI riPSCs, clone T1-3, at passage 20 when cultured with
3i-medium indicate trisomy of chromosome 9 in 2 out of 50 cells,
including an XY gender chromosome, but within normal range of
polyploidy. A few cells exhibiting trisomy of chromosome 9 in
another two clones were cultured with 3i-medium.
(TIF)
Figure S2 Phenotype of chimeric rat derived from DA
riPSCs, clone T4-30. (A) EGFP expression in testis. (B)
Immunostaining of chimeric rat testis. HMV/DTT (Alexa546)
or EGFP fluorescence was observed in testis. EGFP was derived
from riPSCs.
(TIF)
Table S1 Summary of offspring-rat generation from
riPSCs.
(DOC)
Table S2 Summary of primer sequences.
(DOCX)
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